Targeting RET for thyroid cancer therapy
- 1 February 2009
- journal article
- editorial
- Published by Elsevier BV in Biochemical Pharmacology
- Vol. 77 (3), 297-309
- https://doi.org/10.1016/j.bcp.2008.10.033
Abstract
No abstract availableKeywords
This publication has 75 references indexed in Scilit:
- A Novel RET Kinase–β-Catenin Signaling Pathway Contributes to Tumorigenesis in Thyroid CarcinomaCancer Research, 2008
- New insights in thyroid follicular cell biology and its impact in thyroid cancer therapyEndocrine-Related Cancer, 2007
- Oncogene addiction: setting the stage for molecularly targeted cancer therapyGenes & Development, 2007
- Current concepts in RET-related genetics, signaling and therapeuticsTrends in Genetics, 2006
- RET and neuroendocrine tumorsPituitary, 2006
- RET as a Diagnostic and Therapeutic Target in Sporadic and Hereditary Endocrine TumorsEndocrine Reviews, 2006
- RET receptor signaling: Dysfunction in thyroid cancer and Hirschsprung's diseasePathology International, 2006
- RET tyrosine kinase signaling in development and cancerCytokine & Growth Factor Reviews, 2005
- Angiogenesis in Benign and Malignant Thyroid DiseaseThyroid®, 2005
- The RET proto‐oncogene: A molecular therapeutic target in thyroid cancerCancer Science, 2005